TY  - GEN
AU  - Walter,Eva
AU  - Schmitt,Thomas
AU  - Dietrich,Sascha
AU  - Ho,Anthony
AU  - Witzens-Harig,Mathias
TI  - Rituximab and bendamustine in patients with CD20+ diffuse large B-cell lymphoma not eligible for cyclophosphamide, doxorubicin, vincristine and prednisone-like chemotherapy
SN  - 1029-2403
PY  - 2013///0619
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - administration & dosage
KW  - Antigens, CD20
KW  - analysis
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Bendamustine Hydrochloride
KW  - Cyclophosphamide
KW  - Doxorubicin
KW  - Female
KW  - Humans
KW  - Lymphoma, Large B-Cell, Diffuse
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Nitrogen Mustard Compounds
KW  - Prednisone
KW  - Retrospective Studies
KW  - Rituximab
KW  - Vincristine
N1  - Publication Type: Letter
UR  - https://doi.org/10.3109/10428194.2012.682311
ER  -